A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Clinical trial NCT01346358 · COMPLETED
Trial details
- NCT number
- NCT01346358
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-15
- Primary completion
- 2018-05-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.